Christopher K Zarins

This inventor holds 43 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Cardiovascular Treatment Planning. Top assignee: Heartflow, Inc.. Active years: 2012-2025.

USPTO Granted Patents = 43 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 13 (Patent Applications = 14)

Average Co-Inventor Count = 3.9

ph-index = 20

Forward Citations = 1,380(Granted Patents)

Location History:

Menlo Park, CA (US) (2012 - 2022)
Menlo, CA (US) (2019 - 2022)
Austin, TX (US) (2020 - 2024)
Redwood City, CA (US) (2021 - 2024)

Company Filing History:

43 out of 330

Heartflow, Inc.

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Plaque Progression

Treatment Planning

Cardiovascular Disease

Embolism Prediction

Organ Transplantation

Anatomical Modeling

Risk Assessment

Vessel Reactivity

Occluded Arteries

Simulation Techniques

Bioheat Transfer

Hemodialysis Access

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502219 - Systems and methods for treatment planning based on plaque progression and regression curves (2025-12-23),

2. 12478430 - Systems and methods for treatment planning based on plaque progression and regression curves (2025-11-25),

3. 12394528 - Systems and methods for simulation of occluded arteries and optimization of occlusion-based treatments (2025-08-19),

4. 12390274 - Systems and methods of processing images to determine patient-specific plaque progression based on the processed images (2025-08-19),

5. 12387849 - Systems and methods for vessel reactivity to guide diagnosis or treatment of cardiovascular disease (2025-08-12),

6. 12336763 - Systems and methods for treatment planning based on plaque progression and regression curves (2025-06-24),

7. 12310759 - Systems and methods for diagnosis, risk assessment, and/or virtual treatment assessment of visceral ischemia (2025-05-27),

8. 11944387 - Systems and methods for risk assessment and treatment planning of arterio-venous malformation (2024-04-02),

9. 11918293 - Systems and methods for assessing organ and/or tissue transplantation by simulating one or more transplant characteristics (2024-03-05),

10. 11862342 - Systems and methods for embolism prediction using embolus source and destination probabilities (2024-01-02),

11. 11854704 - Systems and methods for anatomical modeling using information obtained from a medical procedure (2023-12-26),

12. 11646118 - Systems and methods for embolism prediction using embolus source and destination probabilities (2023-05-09),

13. 11638609 - Systems and methods for risk assessment and treatment planning of arterio-venous malformation (2023-05-02),

14. 11424038 - Systems and methods for anatomical modeling using information obtained from a medical procedure (2022-08-23),

15. 11423805 - Systems and methods for modeling nutrient transport and/or predicting weight change (2022-08-23),

Title: Innovations in Medical Technology: The Contributions of Christopher K Zarins

Introduction: Christopher K Zarins, based in Menlo Park, California, is a prominent inventor in the field of medical technology, particularly in risk assessment and treatment planning for vascular anomalies. With a remarkable portfolio of 36 patents, Zarins is recognized for his innovative contributions that enhance patient care and surgical outcomes.

Latest Patents: Among his latest patents, Zarins has developed systems and methods for the risk assessment and treatment planning of arterio-venous malformations (AVMs). This computer-implemented method involves analyzing patient-specific models to identify associated blood vessels and estimate the risk of undesirable outcomes through blood flow simulations. Additionally, he holds a patent for systems and methods that assess organ and tissue transplantation by simulating transplantation characteristics. This process includes constructing unified models from patient-specific anatomical data, allowing for the evaluation of blood flow dynamics crucial for successful transplants.

Career Highlights: Throughout his career, Zarins has been instrumental in pushing the boundaries of medical technology. His work at Heartflow, Inc. focuses on implementing advanced computational methods to improve patient-specific healthcare solutions. His inventions pave the way for more precise medical interventions, particularly in the context of cardiovascular health and transplantation.

Collaborations: Christopher K Zarins has worked alongside respected colleagues in the field, such as Leo John Grady and Charles Anthony Taylor, Jr. Their collaborative efforts have significantly advanced the capabilities of medical imaging and surgical planning, further enhancing the impact of their combined innovations in patient care.

Conclusion: Christopher K Zarins is a leading figure in the realm of medical technology innovation. His extensive patent portfolio underscores his commitment to improving surgical outcomes through advanced computational methods. As he continues to collaborate with fellow experts, Zarins' work promises to further revolutionize the landscape of medical technology, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]